Elad Ziv MD
Associate Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
1701 Divisadero StreetSan Francisco, CA 94143
Phone+1 415-353-7300
Fax+1 415-353-7901
Dr. Ziv is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999- University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1998 - 2025
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.Pooja Middha, Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas
Journal for Immunotherapy of Cancer. 2025-03-28 - Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.Peter Orchard, Thomas W Blackwell, Linda Kachuri, Peter J Castaldi, Michael H Cho
Medrxiv. 2025-02-21 - Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.Xiaosong Huang, Paul C Lott, Donglei Hu, Valentina A Zavala, Zoeb N Jamal
Cancer Epidemiology, Biomarkers & Prevention. 2025-02-06
Abstracts/Posters
- Germline Variation Predicts Treatment Response in Multiple MyelomaElad Ziv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall SurvivalElad Ziv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
New Study by HBKU's Qatar Computing Research Institute and Sidra Medicine Reveals Genetic Influence on Cancer Immune ResponsivenessFebruary 17th, 2021- Inherited Genetic Variation Plays Role in Immune Response to Cancer TreatmentFebruary 11th, 2021
- Inherited Genetic Variation May Affect the Response to Cancer ImmunotherapyFebruary 10th, 2021
- Join now to see all
Grant Support
- Evaluating the clinical implications for ACKR1/DARC associated neutropeniaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2027
- Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026
- Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026
- Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026
- Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026
- Epigenomics of asthma risk factors and clinical subtypes in minority childrenUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2025
- Training in the Molecular & Genetic Epidemiology of CancerUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2004–2025
- Training in the Molecular & Genetic Epidemiology of CancerUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2004–2025
- Training in the Molecular & Genetic Epidemiology of CancerUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2004–2025
- Admixture Mapping For Breast Cancer In LatinasNational Cancer Institute2007–2011
- Breast Cancer, Breast Density &Admixture Among LatinasNational Cancer Institute2004–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
